title: An open letter to all members of the IASLC.
authors.forename: Fergus
authors.initials: F
authors.lastname: Macbeth
authors.forename: Richard
authors.initials: R
authors.lastname: Stephens
authors.forename: Raymond P
authors.initials: RP
authors.lastname: Abratt
authors.forename: Roderigo
authors.initials: R
authors.lastname: Arriagada
authors.forename: David
authors.initials: D
authors.lastname: Ball
authors.forename: Andrea
authors.initials: A
authors.lastname: Bezjak
authors.forename: Lucinda
authors.initials: L
authors.lastname: Billingham
authors.forename: John
authors.initials: J
authors.lastname: Crowley
authors.forename: Mary
authors.initials: M
authors.lastname: O'Brien
authors.forename: Tom
authors.initials: T
authors.lastname: Shakespeare
authors.forename: Elinor
authors.initials: E
authors.lastname: Thompson
authors.forename: Jan
authors.initials: J
authors.lastname: van Meerbeeck
mesh_terms: D035843:Biomedical Research / Q000639:trends*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D018401:Sample Size